GSA Capital Partners’s DarioHealth DRIO Stock Holding History

GSA Capital Partners’s Portfolio DRIO Stock Details DRIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,336	Closed	-$911K	–	1490
2021 Q3	$911K	Buy	+3,336	New	+$962K	0.09%	354

Other funds holding DRIO

CHM

Collaborative Holdings Management New York $49.2M AUM 119.38% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

L1 Capital Melbourne VIC 3000, Australia $2.55B AUM 80.12% 1-Year Est. Return

AWAM

Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GSA Capital Partners's DRIO Position: Q4 2021 in Review

GSA Capital Partners sold out of DarioHealth (DRIO) in Q4 2021, closing a stake of 3,336 shares — an estimated $911K sold.

GSA Capital Partners first reported a position in DRIO in Q3 2021 and held it in 1 quarter. The position peaked at $911K in Q3 2021. 60 funds tracked by Wall St. Rank hold DRIO as of Q4 2021.

GSA Capital Partners reported no remaining DarioHealth position as of Q4 2021 after selling out during the quarter.
GSA Capital Partners sold 3,336 DarioHealth shares in Q4 2021, an estimated $911K.
GSA Capital Partners first reported a position in DarioHealth in Q3 2021 and held it in 1 quarter.
GSA Capital Partners's DarioHealth position peaked at $911K in Q3 2021.
60 funds tracked by Wall St. Rank held DarioHealth as of Q4 2021.

Based on GSA Capital Partners's 13F filing for Q4 2021, filed 14 Feb 2022.